VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 79 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,100 | -35.4% | 1,174,087 | -4.5% | 0.00% | -50.0% |
Q2 2023 | $14,084 | +102.6% | 1,229,981 | +36.4% | 0.00% | +100.0% |
Q1 2023 | $6,951 | +42.9% | 901,465 | +13.1% | 0.00% | 0.0% |
Q4 2022 | $4,863 | -99.9% | 797,321 | -5.5% | 0.00% | 0.0% |
Q3 2022 | $4,996,000 | +2.1% | 843,711 | +1.9% | 0.00% | 0.0% |
Q2 2022 | $4,893,000 | +1322.4% | 827,950 | +1735.8% | 0.00% | – |
Q1 2022 | $344,000 | +39.8% | 45,100 | -50.4% | 0.00% | – |
Q4 2021 | $246,000 | +4.7% | 90,900 | +1.7% | 0.00% | – |
Q3 2021 | $235,000 | -10.3% | 89,400 | +40.8% | 0.00% | – |
Q2 2021 | $262,000 | -14.9% | 63,500 | -2.9% | 0.00% | – |
Q1 2021 | $308,000 | -75.0% | 65,378 | -50.2% | 0.00% | – |
Q4 2018 | $1,233,000 | -73.1% | 131,202 | -45.9% | 0.00% | -100.0% |
Q3 2018 | $4,587,000 | +614.5% | 242,434 | +637.9% | 0.00% | – |
Q2 2018 | $642,000 | -52.3% | 32,854 | -78.2% | 0.00% | – |
Q2 2017 | $1,347,000 | +71.6% | 150,384 | +153.6% | 0.00% | – |
Q1 2017 | $785,000 | -40.2% | 59,291 | -42.5% | 0.00% | – |
Q4 2016 | $1,313,000 | – | 103,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |